cilengitide has been researched along with thioacetamide in 1 studies
| Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (thioacetamide) | Trials (thioacetamide) | Recent Studies (post-2010) (thioacetamide) |
|---|---|---|---|---|---|
| 194 | 29 | 133 | 1,705 | 4 | 655 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goodman, SL; Ledermann, M; Niedobitek, G; Patsenker, E; Popov, Y; Sägesser, H; Schneider, V; Schuppan, D; Stickel, F | 1 |
1 other study(ies) available for cilengitide and thioacetamide
| Article | Year |
|---|---|
Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Movement; Cell Proliferation; Disease Models, Animal; Endothelium, Vascular; gamma-Glutamyltransferase; Hepatic Stellate Cells; Hypoxia-Inducible Factor 1, alpha Subunit; Integrin alphaVbeta3; Ligation; Liver; Liver Cirrhosis; Male; Neovascularization, Physiologic; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Wistar; Snake Venoms; Thioacetamide | 2009 |